Ensign Peak Advisors’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-62,150
| Closed | -$159K | – | 1702 |
|
|
2024
Q4 | $159K | Buy |
62,150
+2,500
| +4% | +$6.4K | ﹤0.01% | 1699 |
|
|
2024
Q3 | $222K | Hold |
59,650
| – | – | ﹤0.01% | 1690 |
|
|
2024
Q2 | $377K | Hold |
59,650
| – | – | ﹤0.01% | 1660 |
|
|
2024
Q1 | $320K | Buy |
+59,650
| New | +$320K | ﹤0.01% | 1684 |
|
|
2022
Q4 | – | Sell |
-57,690
| Closed | -$287K | – | 1978 |
|
|
2022
Q3 | $287K | Sell |
57,690
-42,460
| -42% | -$211K | ﹤0.01% | 1728 |
|
|
2022
Q2 | $373K | Buy |
100,150
+79,300
| +380% | +$295K | ﹤0.01% | 1581 |
|
|
2022
Q1 | $117K | Buy |
20,850
+16,290
| +357% | +$91.4K | ﹤0.01% | 1997 |
|
|
2021
Q4 | $28K | Buy |
+4,560
| New | +$28K | ﹤0.01% | 2171 |
|